Fran Schulz - Mar 7, 2025 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Director
Signature
/s/ Robert Cutler, attorney-in-fact
Stock symbol
SNTI
Transactions as of
Mar 7, 2025
Transactions value $
$0
Form type
4
Date filed
3/11/2025, 04:21 PM
Previous filing
Dec 10, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNTI Stock Option (Right to Buy) Award $0 +43.9K $0.00 43.9K Mar 7, 2025 Common Stock 43.9K $3.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date.